Health Condition 1: L80- Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients aged 18-60 years. 2)Vitiligo patients with stable lesions for at least one year. 3)Patients who are willing to give consent.
Exclusion criteria
Exclusion criteria: 1)Patients with unstable vitiligo. 2)Patients who are not willing to give consent. 3)Infections. 4)Patients with bleeding disorders. 5)Patients on anticoagulants. 6)Pregnant and breastfeeding women. 7)Patients with history of skin cancer, keloid, hypertrophic scar, psoriasis, lichen planus, photosensitivity disorders and Koebner’s phenomenon.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study is expected to reveal the efficacy of combining Platelet Rich Plasma with 308-nm Excimer laser therapy compared to 308-nm Excimer laser therapy alone in Stable Vitiligo lesions.Timepoint: Baseline and after 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects will be noted for both Platelet Rich Plasma & Excimer Laser treatments during each visitTimepoint: Baseline & weekly twice for 4 months | — |
Countries
India
Contacts
GSL MEDICAL COLLEGE AND GENERAL HOSPITAL